Elsevier

Brain Research

Volume 646, Issue 1, 16 May 1994, Pages 13-18
Brain Research

Localization of striatal and nigral tachykinin receptors in the rat

https://doi.org/10.1016/0006-8993(94)90052-3Get rights and content

Abstract

The effects of lesioning mesostriatal dopamine projections or striatal neurons on tachykinin binding in the basal ganglia were assessed in the rat. 6-Hydroxydopamine lesions of the medial forebrain bundle destroyed striatal dopamine terminals as assessed by [3H]mazindol autoradiography, but did not significantly affect the binding of NK-1 ([3H][Sar9, Met(O2)11]substance P) or NK-3 ([3H]senktide) tachykinin ligands in the striatum. 6-Hydroxydopamine lesions significantly reduced NK-3 binding in the substantia nigra pars compacta, but not the ventral tegmental area. In contrast, striatal quinolinic acid lesions reduced both NK-1 and NK-3 binding in the striatum, but failed to affect NK-3 binding in the substantia nigra. These findings suggest that both NK-1 and NK-3 receptors within the striatum are predominantly post-synaptic with respect to dopamine neurons, whereas nigral NK-3 receptors are located on dopaminergic neurons.

Reference (31)

Cited by (44)

  • A Second Wave for the Neurokinin Tac2 Pathway in Brain Research

    2021, Biological Psychiatry
    Citation Excerpt :

    Moreover, NKB infusion in the nucleus basalis magnocellularis prevents choline acetyltransferase decline in the cortex (48) and stimulates acetylcholine esterase activity in aging (49). It is worth noting that part of the above-described effects involve the dopaminergic system because the NK3R is located on dopamine nerve terminals within the striatum (8). Furthermore, the influence of Tac2 on the cholinergic system in aging and Alzheimer’s disease could represent a therapeutic target for other disorders such as anxiety (40,50).

  • Mapping the binding pocket of a novel, high-affinity, slow dissociating tachykinin NK<inf>3</inf> receptor antagonist: Biochemical and electrophysiological characterization

    2014, Neuropharmacology
    Citation Excerpt :

    It is prominently expressed in limbic areas of the brain, many of which have been implicated in schizophrenia (Harrison, 1999). Importantly, the NK3 receptor is also located on dopaminergic neurons in the midbrain regions such as substantia nigra (A9), ventral tegmental area and nucleus raphe linealis (A10) (Chen et al., 1998; Langlois et al., 2001; Stoessl, 1994). Activation of the midbrain NK3 receptor with the endogenous ligand NKB or the highly specific agonist succinyl-DFMe-FGLM-NH2 (senktide) increased the firing frequency of dopaminergic neurons and as a consequence the dopamine (DA) release in the nucleus accumbens (Alonso et al., 1996; Marco et al., 1998; Nalivaiko et al., 1997).

  • Characterization of nuclear neurokinin 3 receptor expression in rat brain

    2011, Neuroscience
    Citation Excerpt :

    Reducing the AB concentration was necessary to detect this increase because the higher concentration of AB that was used in Fig. 3B resulted in a maximal signal in nuclear fractions from normotensive control animals that obscured the hydralazine-induced increase. NK3-Rs are widely distributed in the brain (Stoessl and Hill, 1990; Stoessl, 1994; Ding et al., 1996; Shughrue et al., 1996; Yip and Chahl, 2000; Harrison et al., 2004), and intraventricular injection of senktide has been shown to induce fos expression in many of these areas (Smith and Flynn, 2000). As shown in Figs. 6 and 7, we confirmed the expression of NK3-R in whole tissue and nuclear fractions obtained from punches of Caud/putamen, LS, BNST, amygdala, MPOA, PVN, SN, and VTA using both the N-terminal and 2nd extracellular loop ABs.

  • Predominant surface distribution of neurokinin-3 receptors in non-dopaminergic dendrites in the rat substantia nigra and ventral tegmental area

    2007, Neuroscience
    Citation Excerpt :

    The differential subcellular distributions of NK1 and NK3 receptors in the SN and VTA suggest different functional sites for activation of distinct subtypes of neurokinin receptors. The presence of NK3 gold particles in midbrain TH-labeled dendrites is consistent with the known involvement of NK3 receptors in the modulation of the nigrostriatal and mesocorticolimbic DA pathways in the respective SN and VTA (Elliott et al., 1991; Humpel et al., 1991; Humpel and Saria, 1993; Stoessl, 1994; Bannon and Whitty, 1995; Chen et al., 1998; Marco et al., 1998; Friedman et al., 2002; Bishop and Walker, 2004). In DA neurons, the NK3 gold particles were however largely cytoplasmic, suggesting that they are not locally activated.

View all citing articles on Scopus
View full text